• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于磁共振成像的 T 分期预测根治性前列腺切除术后生化复发:迈向 iTNM 分类的一步。

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

机构信息

Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France; Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France; Department of Urology, La Conception Hospital, Aix-Marseille University, APHM, Marseille, France; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.

Department of Urology, La Conception Hospital, Aix-Marseille University, APHM, Marseille, France.

出版信息

Eur Urol Oncol. 2023 Aug;6(4):406-413. doi: 10.1016/j.euo.2022.09.005. Epub 2022 Oct 21.

DOI:10.1016/j.euo.2022.09.005
PMID:36280445
Abstract

BACKGROUND

Local staging of prostate cancer (PCa) still relies on digital rectal examination (DRE), which therefore remains the standard for risk stratification in guideline recommendations, clinical trials, and patient counseling. This issue is increasingly controversial as multiparametric magnetic resonance imaging (mpMRI) has become the most influential diagnostic tool for local staging of PCa over the past two decades.

OBJECTIVE

To compare various models of T category based on DRE or mpMRI to predict early biochemical recurrence (BCR) after radical prostatectomy (RP).

DESIGN, SETTING, AND PARTICIPANTS: A retrospective multicenter cohort study was conducted between 2014 and 2021. A total of 1436 patients were recruited across eight referral centers in France, Italy, Switzerland, and Belgium.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

BCR was defined as two prostate-specific antigen values of ≥0.2 ng/ml during follow-up. Harrell's concordance index (C index) was used to compare the discrimination of four models of T staging based on DRE (model 1: cT1 vs cT2 vs cT3) or mpMRI (model 2: organ-confined disease vs extracapsular extension [iECE] vs seminal vesicle invasion [iSVI]; model 3: Prostate Imaging-Reporting and Data System [PI-RADS] ≤3 vs PI-RADS 4 vs PI-RADS 5; and model 4: iT2a [PI-RADS ≤3] vs iT2b [PI-RADS 4] vs iT2c [PI-RADS 5 excluding ECE or SVI] vs iT3a [ECE] vs iT3b [SVI]) to predict BCR.

RESULTS AND LIMITATIONS

Overall, 74 (5%), 845 (59%), 482 (34%), and 35 (2%) patients had low-, intermediate-, high-, and very high-risk PCa, respectively, according to the Mazzone risk classification. After median follow-up of 16 mo, 113 patients experienced BCR. Although the new five-group mpMRI-based T classification system (model 4) had the highest prognostic discrimination (C index 0.694) for predicting early BCR on multivariable analysis, there was overlap between the 95% confidence intervals of the models. On sensitivity analysis, the new mpMRI-based T staging still had a higher C index than DRE for predicting BCR when excluding cN1 patients and comparing it with a five-group DRE-based T classification (cT1c vs cT2a vs cT2b vs cT2c vs cT3), but the overlap between the 95% confidence intervals of the models remained. The main limitation is the short follow-up.

CONCLUSIONS

We described an alternative mpMRI-based T staging for prediction of early BCR after RP for PCa. Our results need to be validated externally before they can be applied in clinical practice.

PATIENT SUMMARY

At present, digital rectal examination of the prostate is used to stage prostate cancer. We developed an alternative model for staging that uses information from magnetic resonance imaging (MRI) scans to predict cancer outcomes for men undergoing surgical removal of the prostate.

摘要

背景

前列腺癌(PCa)的局部分期仍然依赖于直肠指检(DRE),因此它仍然是指南推荐、临床试验和患者咨询中风险分层的标准。随着过去二十年多参数磁共振成像(mpMRI)成为 PCa 局部分期最有影响力的诊断工具,这一问题变得越来越有争议。

目的

比较基于 DRE 或 mpMRI 的各种 T 分期模型,以预测根治性前列腺切除术后(RP)的早期生化复发(BCR)。

设计、地点和参与者:这是一项回顾性多中心队列研究,于 2014 年至 2021 年进行。共招募了来自法国、意大利、瑞士和比利时 8 个转诊中心的 1436 名患者。

结局测量和统计分析

BCR 定义为随访期间两次前列腺特异性抗原值≥0.2ng/ml。采用 Harrell 一致性指数(C 指数)比较基于 DRE 的四种 T 分期模型(模型 1:cT1 与 cT2 与 cT3)或 mpMRI(模型 2:器官局限性疾病与包膜外延伸[ECE]与精囊侵犯[SVI];模型 3:前列腺影像报告和数据系统[PI-RADS]≤3 与 PI-RADS 4 与 PI-RADS 5;模型 4:iT2a [PI-RADS≤3]与 iT2b [PI-RADS 4]与 iT2c [PI-RADS 5 排除 ECE 或 SVI]与 iT3a [ECE]与 iT3b [SVI])预测 BCR 的能力。

结果和局限性

根据 Mazzone 风险分类,总体而言,分别有 74(5%)、845(59%)、482(34%)和 35(2%)名患者为低危、中危、高危和极高危 PCa。在中位随访 16 个月后,113 名患者发生 BCR。尽管新的基于五组 mpMRI 的 T 分类系统(模型 4)在多变量分析中对预测早期 BCR 具有最高的预后判别能力(C 指数 0.694),但各模型的 95%置信区间仍有重叠。在敏感性分析中,当排除 cN1 患者并将新的基于 mpMRI 的 T 分期与基于五组 DRE 的 T 分类(cT1c 与 cT2a 与 cT2b 与 cT2c 与 cT3)进行比较时,新的基于 mpMRI 的 T 分期仍比 DRE 具有更高的 C 指数来预测 BCR,但各模型的 95%置信区间仍有重叠。主要的局限性是随访时间短。

结论

我们描述了一种用于预测 RP 后 PCa 早期 BCR 的替代基于 mpMRI 的 T 分期。在将其应用于临床实践之前,我们需要对其进行外部验证。

患者总结

目前,前列腺的直肠指检用于分期前列腺癌。我们开发了一种替代模型,该模型使用磁共振成像(MRI)扫描信息来预测接受前列腺切除术的男性的癌症结果。

相似文献

1
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.基于磁共振成像的 T 分期预测根治性前列腺切除术后生化复发:迈向 iTNM 分类的一步。
Eur Urol Oncol. 2023 Aug;6(4):406-413. doi: 10.1016/j.euo.2022.09.005. Epub 2022 Oct 21.
2
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.磁共振成像多参数分析及系统活检对经磁共振成像靶向活检诊断前列腺癌患者根治性前列腺切除术后生化复发的预测价值
Eur Urol Oncol. 2020 Dec;3(6):739-747. doi: 10.1016/j.euo.2020.07.008. Epub 2020 Aug 23.
3
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.基于临床和多参数磁共振成像参数对前列腺癌根治术候选患者进行风险分层:新型风险组的开发与外部验证
Eur Urol. 2022 Feb;81(2):193-203. doi: 10.1016/j.eururo.2021.07.027. Epub 2021 Aug 13.
4
Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.比较3-T多参数磁共振成像和Partin表预测前列腺癌根治术后器官局限性前列腺癌的情况。
Urol Oncol. 2014 Nov;32(8):1292-9. doi: 10.1016/j.urolonc.2014.04.017. Epub 2014 May 23.
5
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.基于 MRI 的分期与病理分期预测前列腺癌根治术后生化复发的比较。
AJR Am J Roentgenol. 2023 Dec;221(6):773-787. doi: 10.2214/AJR.23.29609. Epub 2023 Jul 5.
6
Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.基于 PI-RADS 版本 2 预测前列腺癌根治术后的生化复发:初步结果。
Eur Radiol. 2016 Aug;26(8):2502-9. doi: 10.1007/s00330-015-4077-5. Epub 2015 Nov 11.
7
The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy Specimen.多参数 MRI(mpMRI)在预测前列腺根治性切除术标本中前列腺癌不良病理中的作用。
Urol Int. 2024;108(2):146-152. doi: 10.1159/000536256. Epub 2024 Jan 19.
8
Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.多参数 MRI 检查显示隐匿性前列腺癌行根治性前列腺切除术的肿瘤学结局的临床意义和预测因素。
BMC Cancer. 2018 Nov 1;18(1):1057. doi: 10.1186/s12885-018-4955-8.
9
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.多参数磁共振成像联合磁共振成像靶向和系统活检对接受根治性前列腺切除术的前列腺癌患者不良病理特征预测的关键联合价值。
Eur Urol. 2020 Jun;77(6):733-741. doi: 10.1016/j.eururo.2019.09.005. Epub 2019 Sep 21.
10
Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.多参数 MRI 预测真实世界前列腺癌病理和肿瘤分期的准确性评估:一项多中心研究。
BJU Int. 2019 Aug;124(2):297-301. doi: 10.1111/bju.14696. Epub 2019 Feb 25.

引用本文的文献

1
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.基于PSMA PET/CT的局部分期在预测根治性前列腺切除术后生化复发中的预后价值。
Eur J Nucl Med Mol Imaging. 2025 Jul 28. doi: 10.1007/s00259-025-07455-0.
2
Bi-parametric MRI-based quantification radiomics model for the noninvasive prediction of histopathology and biochemical recurrence after prostate cancer surgery: a multicenter study.基于双参数MRI的定量放射组学模型用于前列腺癌手术后组织病理学和生化复发的无创预测:一项多中心研究
Abdom Radiol (NY). 2025 Mar 17. doi: 10.1007/s00261-025-04873-4.
3
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer.
ISUP 分级 4 或 5 级前列腺癌患者的 MRI 特征和肿瘤学随访。
Abdom Radiol (NY). 2024 Jan;49(1):192-201. doi: 10.1007/s00261-023-04073-y. Epub 2023 Oct 31.
4
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer.达米科高危标准的类型和数量与病理上非器官局限性前列腺癌发生率的相关性。
Cent European J Urol. 2023;76(2):104-108. doi: 10.5173/ceju.2023.030. Epub 2023 Apr 30.
5
How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery.当代如何管理T3b期前列腺癌:手术的益处
Eur Urol Open Sci. 2023 May 29;53:55-57. doi: 10.1016/j.euros.2023.05.004. eCollection 2023 Jul.